Mangrove Partners’s Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 CNDA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-70,504
Closed -$715K 239
2023
Q1
$715K Buy
+70,504
New +$7.92K 0.05% 183

Other funds holding CNDA.WS

Mangrove Partners's CNDA.WS Position: Q2 2023 in Review

Mangrove Partners sold out of Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (CNDA.WS) in Q2 2023, closing a stake of 70,504 shares — an estimated $715K sold.

Mangrove Partners first reported a position in CNDA.WS in Q1 2023 and held it in 1 quarter. The position peaked at $715K in Q1 2023. 28 funds tracked by Wall St. Rank hold CNDA.WS as of Q2 2023.

  • Mangrove Partners reported no remaining Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Mangrove Partners sold 70,504 Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q2 2023, an estimated $715K.
  • Mangrove Partners first reported a position in Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q1 2023 and held it in 1 quarter.
  • Mangrove Partners's Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $715K in Q1 2023.
  • 28 funds tracked by Wall St. Rank held Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q2 2023.

Based on Mangrove Partners's 13F filing for Q2 2023, filed 14 Aug 2023.